Search

everythinglearnresearchcommunity

for

Search:↓

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

IGF-1 affects hair loss and could be a potential treatment.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Ozone therapy might improve cancer treatment and reduce its side effects.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Non-immune factors play a significant role in alopecia areata.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Different treatments for alopecia areata have unpredictable results and varying success rates.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.